Pipeline
Our Pioneering Pipeline of True Human Antibodies
Our pipeline addresses a wide range of unmet medical needs.
Anti-inflammatory Therapy
Harnessing Human Immunity to Stop Harmful Inflammation
Phase 2/3
Target: Interleukin-1 Alpha
Oncology — Pancreatic Cancer
Targeting inflammatory pathways in advanced cancers
Phase 1/2
Target: IL-1α
Rheumatoid Arthritis
Novel approach to autoimmune inflammation
Phase 2
Target: IL-1α (Natrunix)
Infectious Diseases
Natural Human Immunity — What Better Way to Treat Infectious Disease?
Preclinical / Phase 1
Target: Multiple targets